[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2022 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Jun-2022 [#2]
Profit Trend
QoQ- 80.39%
YoY- 10.9%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 367,991 367,683 321,893 302,044 295,852 257,250 240,355 7.35%
PBT 44,805 48,119 43,373 37,118 37,102 26,170 24,764 10.38%
Tax -9,633 -11,517 -10,369 -8,828 -8,721 -5,184 -5,559 9.59%
NP 35,172 36,602 33,004 28,290 28,381 20,986 19,205 10.60%
-
NP to SH 35,172 36,602 33,004 28,290 28,381 20,986 19,217 10.59%
-
Tax Rate 21.50% 23.93% 23.91% 23.78% 23.51% 19.81% 22.45% -
Total Cost 332,819 331,081 288,889 273,754 267,471 236,264 221,150 7.04%
-
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div 4,788 4,734 3,530 3,421 6,618 4,199 6,973 -6.07%
Div Payout % 13.62% 12.93% 10.70% 12.10% 23.32% 20.01% 36.29% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
NOSH 961,942 952,239 706,330 684,383 661,881 650,902 278,959 22.90%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 9.56% 9.95% 10.25% 9.37% 9.59% 8.16% 7.99% -
ROE 5.25% 5.77% 5.37% 4.86% 5.64% 9.99% 4.15% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 38.42 38.83 45.58 44.13 44.70 91.88 86.16 -12.58%
EPS 3.68 3.88 4.67 4.13 4.26 3.22 6.88 -9.89%
DPS 0.50 0.50 0.50 0.50 1.00 1.50 2.50 -23.51%
NAPS 0.70 0.67 0.87 0.85 0.76 0.75 1.66 -13.39%
Adjusted Per Share Value based on latest NOSH - 952,239
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 38.25 38.22 33.46 31.40 30.76 26.74 24.99 7.34%
EPS 3.66 3.81 3.43 2.94 2.95 2.18 2.00 10.59%
DPS 0.50 0.49 0.37 0.36 0.69 0.44 0.72 -5.89%
NAPS 0.697 0.6595 0.6387 0.6047 0.5229 0.2183 0.4814 6.35%
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 1.30 1.20 3.03 1.62 1.37 1.30 2.25 -
P/RPS 3.38 3.09 6.65 3.67 3.06 1.41 2.61 4.40%
P/EPS 35.40 31.04 64.83 39.19 31.95 17.34 32.66 1.35%
EY 2.82 3.22 1.54 2.55 3.13 5.77 3.06 -1.35%
DY 0.38 0.42 0.17 0.31 0.73 1.15 1.11 -16.35%
P/NAPS 1.86 1.79 3.48 1.91 1.80 1.73 1.36 5.35%
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 -
Price 1.19 1.34 2.49 3.15 1.41 1.08 2.03 -
P/RPS 3.10 3.45 5.46 7.14 3.15 1.18 2.36 4.64%
P/EPS 32.41 34.66 53.28 76.20 32.88 14.41 29.47 1.59%
EY 3.09 2.88 1.88 1.31 3.04 6.94 3.39 -1.53%
DY 0.42 0.37 0.20 0.16 0.71 1.39 1.23 -16.38%
P/NAPS 1.70 2.00 2.86 3.71 1.86 1.44 1.22 5.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment